Antibody–Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care
56:32
Antibody Drug Conjugates for Cancer
57:00
Capitalizing on Personalized Care in IDH Mutant Gliomas
38:39
Are "forever chemicals" ruining our health? — with PFAs expert Dr. Jesse Goodrich
52:59
Refining the First Strike Against EGFR-Mutated Advanced NSCLC
27:03
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
44:35
Developing Robust Potency Assays for Validation - A Case Study
1:07:00
Watch Drs. Pal, Tannir, & Zhang discuss #RCC updates from #IKCSNA24 - bit.ly/Louisville24Y
5:57